Omron Corp. (OTCMKTS:OMRNY) Sees Significant Increase in Short Interest

Omron Corp. (OTCMKTS:OMRNY) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 27,640 shares, a growth of 116.6% from the February 12th total of 12,759 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 63,509 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 63,509 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.0% of the shares of the stock are short sold.

Omron Stock Down 2.7%

Shares of OTCMKTS OMRNY opened at $28.28 on Friday. The firm has a market capitalization of $5.83 billion, a PE ratio of 35.80, a price-to-earnings-growth ratio of 0.45 and a beta of 0.92. The company has a current ratio of 2.11, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. Omron has a 1 year low of $23.23 and a 1 year high of $35.90. The firm’s 50-day moving average is $28.78 and its 200-day moving average is $27.37.

Omron (OTCMKTS:OMRNY) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). Omron had a return on equity of 2.46% and a net margin of 2.80%.The company had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities analysts expect that Omron will post 0.42 EPS for the current year.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its holdings in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. Institutional investors and hedge funds own 1.09% of the company’s stock.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold”.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.